2009
DOI: 10.1001/archdermatol.2009.235
|View full text |Cite
|
Sign up to set email alerts
|

Pulsed High-Dose Corticosteroids Combined With Low-Dose Methotrexate Treatment in Patients With Refractory Generalized Extragenital Lichen Sclerosus

Abstract: Background: Lichen sclerosus (LS) is a rare, chronic inflammatory skin disease that predominantly affects the anogenital area. A few patients exhibit widespread extragenital disease that may lead to blister formation and superficial erosions. We evaluated the efficacy of pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized LS that had failed to respond to standard topical corticosteroid therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
29
0
2

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(33 citation statements)
references
References 21 publications
2
29
0
2
Order By: Relevance
“…10 Literature shows successful treatment of refractory generalized extragenital lichen sclerosus with pulsed high-dose corticosteroids combined with methotrexate. 26 Histopathological confirmation of oral LS is necessary to rule out other whitish lesions such as lichen planus and localized scleroderma which require different management.…”
Section: Case Reportmentioning
confidence: 99%
“…10 Literature shows successful treatment of refractory generalized extragenital lichen sclerosus with pulsed high-dose corticosteroids combined with methotrexate. 26 Histopathological confirmation of oral LS is necessary to rule out other whitish lesions such as lichen planus and localized scleroderma which require different management.…”
Section: Case Reportmentioning
confidence: 99%
“…Other reported treatments include topical retinoids, topical tacrolimus or pimecrolimus, oral steroids, cyclosporine, phototherapy, laser therapy, and surgical excision 6–8 . Patients with severe and refractory disease may be treated with high‐dose corticosteroids combined with low‐dose methotrexate therapy 9 …”
Section: Discussionmentioning
confidence: 99%
“…Ancak bunlarında teorik olarak malignensi potansiyelleri bulunduğu için komplike olmayan olgularda kullanılmaması tavsiye edilmektedir (35,46,47). Şiddetli ve tedaviye cevap vermeyen LS olgularında literatür verileri sınırlı olmakla birlikte sistemik metotreksat, asitretin ve metotreksatla birlikte puls metilprednizolon tedavisi uygulanabilir (48,49). Tedaviden sonra nüks eden olgularda sekonder enfeksiyonlar, kontakt dermatitler ve malignensiler mutlaka ekarte edilmelidir (35).…”
Section: Liken Sklerozisunclassified